Regeneron Managed Access Program Policy & Clinical Trial site information

Please see the following link for the Managed Access Policy which includes instructions on how a treating physician can submit a compassionate use request on behalf of a patient:Regeneron Managed Access Policy

The clinicaltrials.gov website is now live:  Study Details | NCT07832370 | A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD) | ClinicalTrials.gov